Thank you for Subscribing to Life Science Review Weekly Brief
Depending on the drug's therapeutic area, the total cost associated with all phases of a clinical study might range from 44 million dollars to 115.3 million dollars, according to a report.
FREMONT, CA: If a clinical trial's clinical research team fails to enroll enough study volunteers, the study's timeframe will be extended by default, increasing resource utilization and expenditures. A prolonged study start may cause a drug or treatment to take longer to reach the market, extending both the time and the public's access to it.
Clinical Trial Market
The clinical trial market is massive and fast expanding. Clinicaltrials.gov began with 2,119 active studies in the year 2000 and today has over 280,000 ongoing clinical research projects. This means that the market is increasing in value, with a projected value of 65.2 billion dollars by 2025. Depending on the drug's therapeutic area, the total cost associated with all phases of a clinical study might range from 44 million dollars to 115.3 million dollars, according to a report. Moreover, only one out of every ten medications that undergo clinical trials makes it to market.
Statistics of Patient Recruitment Failures
Along with the growing clinical trial market, there are also significant barriers to patient recruiting. Here are some stats to consider. More than 80 percent of clinical trials in the United States fail to achieve their patient recruiting deadlines, according to the National Institutes of Health (NIH).
These delays raise prices, deplete resources, and lengthen its time to get into the market.
Strategies to Improve Patient Recruitment
There are many theories and suggestions for improving patient recruitment; however, none of them are foolproof and vary depending on the trial. These, on the other hand, may help to improve the situation to some amount.